A detailed history of Redwood Investment Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Redwood Investment Management, LLC holds 2,031 shares of ABBV stock, worth $399,741. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,031
Previous 1,678 21.04%
Holding current value
$399,741
Previous $305,000 20.33%
% of portfolio
0.03%
Previous 0.03%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $54,640 - $63,808
353 Added 21.04%
2,031 $367,000
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $2.5 Million - $2.85 Million
-15,651 Reduced 90.32%
1,678 $305,000
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $567,049 - $638,631
-4,121 Reduced 19.21%
17,329 $2.69 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $1.13 Million - $1.3 Million
8,434 Added 64.8%
21,450 $3.2 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $812,286 - $1.01 Million
-6,130 Reduced 32.02%
13,016 $1.75 Million
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $2.09 Million - $2.41 Million
14,482 Added 310.51%
19,146 $3.05 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $404,911 - $464,406
3,017 Added 183.18%
4,664 $626,000
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $34,955 - $44,439
254 Added 18.23%
1,647 $252,000
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $1.83 Million - $2.27 Million
-13,878 Reduced 90.88%
1,393 $226,000
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $470,758 - $595,645
4,382 Added 40.24%
15,271 $2.07 Million
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $27,238 - $30,919
-256 Reduced 2.3%
10,889 $1.18 Million
Q2 2021

Aug 17, 2021

BUY
$105.21 - $117.21 $215,680 - $240,280
2,050 Added 22.54%
11,145 $1.23 Million
Q1 2021

May 18, 2021

BUY
$102.3 - $112.62 $4,705 - $5,180
46 Added 0.51%
9,095 $984,000
Q1 2021

May 17, 2021

SELL
$102.3 - $112.62 $54,525 - $60,026
-533 Reduced 5.56%
9,049 $979,000
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $105,200 - $142,031
1,307 Added 15.79%
9,582 $1.03 Million
Q3 2020

Nov 16, 2020

SELL
$85.91 - $100.83 $11,683 - $13,712
-136 Reduced 1.62%
8,275 $725,000
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $617,115 - $825,791
8,411 New
8,411 $826,000
Q1 2020

May 13, 2020

SELL
$64.5 - $97.79 $291,153 - $441,424
-4,514 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $3.41 Million - $4.27 Million
-47,313 Reduced 91.29%
4,514 $400,000
Q3 2019

Nov 18, 2019

BUY
$62.98 - $75.72 $910,438 - $1.09 Million
14,456 Added 38.68%
51,827 $3.92 Million
Q2 2019

Aug 15, 2019

SELL
$65.7 - $83.98 $766,390 - $979,626
-11,665 Reduced 23.79%
37,371 $3.01 Million
Q2 2019

Aug 15, 2019

BUY
$65.7 - $83.98 $766,390 - $979,626
11,665 Added 31.21%
49,036 $3.57 Million
Q1 2019

May 16, 2019

BUY
$77.14 - $90.79 $2.88 Million - $3.39 Million
37,371 New
37,371 $3.01 Million
Q4 2018

Feb 13, 2019

SELL
$77.85 - $96.01 $228,567 - $281,885
-2,936 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$88.91 - $98.84 $261,039 - $290,194
2,936 New
2,936 $278,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $348B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Redwood Investment Management, LLC Portfolio

Follow Redwood Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redwood Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redwood Investment Management, LLC with notifications on news.